{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:40:37Z","timestamp":1773268837660,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as Nonalcoholic Fatty Liver Disease (NAFLD), is characterized by an abnormal accumulation of fat in the liver. The causes of MASLD are varied, and include an unhealthy lifestyle, hyperlipidemia, hypertension, and type 2 diabetes mellitus. They are considered to be susceptibility-inducing factors for MASLD, and are strongly associated with obesity. Many researchers have explored the pathogenesis of MASLD in recent years, and have concluded that its development is associated with insulin resistance and impaired fat metabolism, which manifests as a form of metabolic liver injury. Currently available treatments remain challenging to implement, and impose a significant burden on the healthcare system. Neutrophils play an important role in the development of MASLD, and are crucial immune cells that provide the first line of defense against infection and injury. This review examines the pathogenesis of MASLD and the role of neutrophils in the disease, and further explores current advances in MASLD treatment as well as the therapeutic potential of neutrophils.<\/jats:p>","DOI":"10.3389\/fmed.2026.1792366","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:52:53Z","timestamp":1773211973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in the pathogenesis of MASLD and its association with neutrophils"],"prefix":"10.3389","volume":"13","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangfeng","family":"Zi","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine","place":["Zhongshan Hospital, Fudan University, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangcong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","article-title":"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Qi","year":"2024","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.3390\/ijms25084387","article-title":"Alteration of gut microbiota composition in the progression of liver damage in patients with metabolic dysfunction-associated steatotic liver disease (masld)","volume":"25","author":"Zazueta","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e00207","DOI":"10.1097\/HC9.0000000000000207","article-title":"Increasing nonalcoholic fatty liver disease-related mortality rates in the United States from 1999 to 2022","volume":"7","author":"Ilyas","year":"2023","journal-title":"Hepatol Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990\u20132021 to 2045","volume":"30","author":"Kan","year":"2025","journal-title":"Ann Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12325-024-03085-4","article-title":"Understanding MASH: an examination of progression and clinical outcomes by disease severity in the TARGET-NASH database","volume":"42","author":"Luthra","year":"2025","journal-title":"Adv Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s41043-025-00926-y","article-title":"Neutrophil percentage-to-albumin ratio and neutrophil-to-albumin ratio as novel biomarkers for non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"44","author":"El-Sehrawy","year":"2025","journal-title":"J Health Popul Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12013-015-0682-9","article-title":"Neutrophils play a crucial role in the early stage of nonalcoholic steatohepatitis via neutrophil elastase in mice","volume":"73","author":"Zang","year":"2015","journal-title":"Cell Biochem Biophys."},{"key":"B9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13293-023-00569-w","article-title":"Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb\/c mice","volume":"14","author":"Cu\u00f1o-G\u00f3miz","year":"2023","journal-title":"Biol Sex Differ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/life13020419","article-title":"The Essential Role of IL-17 as the Pathogenetic Link between psoriasis and metabolic-associated fatty liver disease","volume":"13","author":"Olveira","year":"2023","journal-title":"Life."},{"key":"B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/cells13110960","article-title":"Combined insults of a MASH diet and alcohol binges activate intercellular communication and neutrophil recruitment via the NLRP3-IL-1\u03b2 Axis in the liver","volume":"13","author":"Babuta","year":"2024","journal-title":"Cells."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/jcm13051406","article-title":"The interplay between liver sinusoidal endothelial cells, platelets, and neutrophil extracellular traps in the development and progression of metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Minciuna","year":"2024","journal-title":"J Clin Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/HEP.0000000000000786","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","volume":"82","author":"Wang","year":"2025","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3350\/cmh.2023.0485","article-title":"Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Le","year":"2024","journal-title":"Clin Mol Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/biomedicines12051105","article-title":"Circulating neutrophil profiles undergo a dynamic shift during metabolic dysfunction-associated steatohepatitis (mash) progression","volume":"12","author":"Maretti-Mira","year":"2024","journal-title":"Biomedicines."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.smim.2023.101849","article-title":"Regulated cell death in neutrophils: from apoptosis to NETosis and pyroptosis","volume":"70","author":"Dejas","year":"2023","journal-title":"Semin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/CEG.S329424","article-title":"Activation and functional priming of blood neutrophils in non-alcoholic fatty liver disease increases in non-alcoholic steatohepatitis","volume":"14","author":"Lauszus","year":"2021","journal-title":"Clin Exp Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"751802","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"107609","DOI":"10.1016\/j.intimp.2021.107609","article-title":"Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease","volume":"97","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2147\/DMSO.S464406","article-title":"The association between neutrophil\/high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in a healthy population","volume":"17","author":"Jia","year":"2024","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/biom13111625","article-title":"The diagnostic, therapeutic and prognostic relevance of neutrophil extracellular traps in polytrauma","volume":"13","author":"Rogers","year":"2023","journal-title":"Biomolecules."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.3390\/ijms24054896","article-title":"Molecular mechanisms of neutrophil extracellular trap (NETs) degradation","volume":"24","author":"Demkow","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1221669","DOI":"10.3389\/fmolb.2023.1221669","article-title":"Cellular heterogeneity and plasticity during NAFLD progression","volume":"10","author":"Park","year":"2023","journal-title":"Front Mol Biosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"167533","DOI":"10.1016\/j.jmb.2022.167533","article-title":"An integrated pharmacological, structural, and genetic analysis of extracellular versus intracellular ROS production in neutrophils","volume":"434","author":"Ellson","year":"2022","journal-title":"J Mol Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/antiox9080759","article-title":"Oxidative stress and pro-inflammatory status in patients with non-alcoholic fatty liver disease","volume":"9","author":"Monserrat-Mesquida","year":"2020","journal-title":"Antioxidants."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.3390\/biomedicines11123216","article-title":"The multicomponent medicinal product hepar compositum reduces hepatic inflammation and fibrosis in a streptozotocin- and high-fat diet-induced model of metabolic dysfunction-associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis","volume":"11","author":"Burmeister","year":"2023","journal-title":"Biomedicines."},{"key":"B36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.5152\/tjg.2020.19403","article-title":"Myeloperoxidase and calprotectin; any role as non-invasive markers for the prediction of inflammation and fibrosis in non-alcoholic steatohepatitis?","volume":"31","author":"Bi\u00e7ak\u00e7i","year":"2020","journal-title":"Turk J Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep4.1566","article-title":"Therapeutic targeting of myeloperoxidase attenuates NASH in mice","volume":"4","author":"Koop","year":"2020","journal-title":"Hepatol Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41419-025-07857-w","article-title":"Exploring the involvement of serine proteases in neutrophil extracellular traps: a review of mechanisms and implications","volume":"16","author":"Korba-Miko\u0142ajczyk","year":"2025","journal-title":"Cell Death Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbalip.2014.07.017","article-title":"Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver","volume":"1842","author":"Asimakopoulou","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B40","doi-asserted-by":"publisher","first-page":"112002","DOI":"10.1016\/j.biopha.2021.112002","article-title":"Lipocalin-2: Structure, function, distribution and role in metabolic disorders","volume":"142","author":"Jaberi","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fphys.2017.00964","article-title":"Lipocalin-2 in fructose-induced fatty liver disease","volume":"8","author":"Lambertz","year":"2017","journal-title":"Front Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"15708","DOI":"10.3390\/ijms232415708","article-title":"Plasma calprotectin levels associate with suspected metabolic-associated fatty liver disease and all-cause mortality in the general population","volume":"23","author":"Bourgonje","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"112151","DOI":"10.1016\/j.diabres.2025.112151","article-title":"IDF. technical working group. 7 management of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes Diabetes","volume":"222","author":"Colagiuri","year":"2025","journal-title":"Res Clin Pract."},{"key":"B44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat Rev Drug Discov."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Raverdy","year":"2024","journal-title":"Nat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1111\/jgh.16723","article-title":"Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis","volume":"39","author":"Chee","year":"2024","journal-title":"J Gastroenterol Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1007\/s00125-016-4084-3","article-title":"Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice","volume":"59","author":"Merry","year":"2016","journal-title":"Diabetologia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jtha.2024.01.022","article-title":"Neutrophil peptidylarginine deiminase 4 plays a systemic role in obesity-induced chronic inflammation in mice","volume":"22","author":"Van Bruggen","year":"2024","journal-title":"J Thromb Haemost."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathwaays","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm14020428","article-title":"The triad of risk: linking MASLD, cardiovascular disease and type 2 diabetes; from pathophysiology to treatment","volume":"14","author":"Michalopoulou","year":"2025","journal-title":"J Clin Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4570219","DOI":"10.1155\/2020\/4570219","article-title":"Circulating neutrophils of nonalcoholic steatohepatitis patients show an activated phenotype and suppress t lymphocytes activity","volume":"2020","author":"Antonucci","year":"2020","journal-title":"J Immunol Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/HEP.0000000000000762","article-title":"Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC","volume":"81","author":"Xia","year":"2025","journal-title":"Hepatology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut."},{"key":"B56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","article-title":"Mechanical stretch increases expression of cxcl1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension","volume":"157","author":"Hilscher","year":"2019","journal-title":"Gastroenterology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2020.11.003","article-title":"Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets","volume":"231","author":"Miele","year":"2021","journal-title":"Transl Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"823511","DOI":"10.3389\/fimmu.2022.823511","article-title":"Neutrophil extracellular traps regulate HMGB1 translocation and kupffer cell M1 polarization during acute liver transplantation rejection","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/life15081306","article-title":"Resmetirom in the management of metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"15","author":"Jamal","year":"2025","journal-title":"Life."},{"key":"B60","doi-asserted-by":"publisher","first-page":"615409","DOI":"10.3389\/fendo.2021.615409","article-title":"Pioglitazone for NAFLD patients with prediabetes or type 2 diabetes mellitus: a meta-analysis","volume":"12","author":"Lian","year":"2021","journal-title":"Front Endocrinol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jamainternmed.2023.8029","article-title":"Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease","volume":"184","author":"Jang","year":"2024","journal-title":"JAMA Intern Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13098-023-01085-y","article-title":"Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Wang","year":"2023","journal-title":"Diabetol Metab Syndr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"622589","DOI":"10.3389\/fendo.2020.622589","article-title":"Comparison of the efficacy of glucagon-like peptide-1 receptor agonists in patients with metabolic associated fatty liver disease: updated systematic review and meta-analysis","volume":"11","author":"Dai","year":"2021","journal-title":"Front Endocrinol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cgh.2024.02.022","article-title":"Safety and efficacy of efruxifermin in combination with a glp-1 receptor agonist in patients with NASH\/MASH and type 2 diabetes in a randomized phase 2 study","volume":"23","author":"Harrison","year":"2025","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J Hepatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1792366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:52:54Z","timestamp":1773211974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1792366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":66,"alternative-id":["10.3389\/fmed.2026.1792366"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1792366","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1792366"}}